Girls Are Missing ADHD Diagnoses Because the System Was Built for Boys

What Busy Philipps described

A Forbes profile published July 4, 2026, covers how Philipps recognized her own ADHD while watching her child go through evaluation. Her symptoms looked nothing like the hyperactive classroom disruption most people picture: she struggled with disorganization, distractibility she kept inside, difficulty managing time, and emotional dysregulation that left her exhausted from trying to hold it together. Before the diagnosis, she said, she was “very, very hard on myself” for what she now understands was her brain working differently, not a personal failing.

Since her diagnosis she has partnered with Supernus Pharmaceuticals to advocate for greater awareness of how ADHD presents in women, a partnership tied to Qelbree, a non-stimulant medication she takes. The commercial relationship is worth noting for context. The scientific problem she is pointing at stands entirely independent of it.

“I was very, very hard on myself,” Philipps said of the years before her diagnosis. Getting the right answer, she added, has helped her “be kinder to myself about it and sort of move through it easier.”

The diagnostic system was not built for how girls actually present

ADHD diagnostic criteria took shape from research populations that skewed heavily male and hyperactive. The child who could not sit still, who blurted answers, who disrupted the classroom, was the template. He got referred. He got evaluated. He got a name for what was happening. The girl who sat quietly staring at nothing, forgot her permission slip again, and cried in the car on the way home got called anxious, emotional, scattered, or a worrier. She got referred to a therapist for her feelings, not an evaluator for her attention system.

The numbers show exactly what that costs. In childhood, boys in clinical settings are diagnosed with ADHD three to four times as often as girls. In population studies that look at actual prevalence rather than who got referred, the gap is far smaller. The difference between those two numbers is not biology. It is bias built into the referral and diagnostic process itself.

Associate Professor Caroline Gurvich and her team at the HER Centre Australia at Monash University surveyed 600 women for a study published in the Journal of Psychiatric Research in 2026. Their conclusion: the gap between male and female diagnosis rates reflects systemic misdiagnosis and underdiagnosis of females, not a male disposition to ADHD. The condition is as common in women. It is just routinely missed, mislabeled, and medicated for the wrong thing. Eighty-eight percent of the women surveyed also reported that ADHD symptoms shifted during their menstrual cycle, a hormonal dynamic the traditional diagnostic picture did not account for at all.

The enemy here is a system, not a clinician. Individual doctors do their best with the tools and training they have. But when a diagnostic framework is built from data that barely included girls, it produces criteria that treat the boy presentation as default and render the quieter, internalizing girl invisible to that framework. Getting the right evaluation means knowing to ask for it before the system prompts you.

What to watch for, and what to ask

If your daughter daydreams during class but does well when she is interested, loses track of assignments, gets flooded by emotions in ways that seem out of proportion, or has been treated for anxiety that does not quite resolve, ADHD is worth putting on the table with a clinician who knows inattentive presentations. Not because a label is the goal, but because treating the wrong thing for years has its own cost.

The tradeoffs are real. A diagnosis can open doors to accommodations and, for some families, medication that meaningfully helps. It can also attach a label to a child who needed a different kind of support, not a clinical identity. The Monash research found that hormonal shifts across puberty, the menstrual cycle, and beyond affect ADHD symptoms in ways not yet built into standard treatment protocols. Knowing that means you can ask better questions: Does my child’s evaluator have experience with inattentive presentations in girls? If attention and emotion have been a struggle, has ADHD been considered, or ruled out only because she did not disrupt class?

The brain your daughter has today is not the brain she will have after a year of the right kind of support, targeted to what her specific processing actually needs. That is not hope. That is what the neuroplasticity research actually shows. Finding the right target is the first step.